Epirubicin combined with oxaliplatin and 5-day continuous infusion of 5-fluorouracil as a first-line treatment for metastatic gastric cancer: treatment outcomes and analysis of prognostic factors.
about
Maintenance treatment of Uracil and Tegafur (UFT) in responders following first-line fluorouracil-based chemotherapy in metastatic gastric cancer: a randomized phase II study.Neutropenia predicts better prognosis in patients with metastatic gastric cancer on a combined epirubicin, oxaliplatin and 5-fluorouracil regimen.Prognostic factors associated with locally advanced gastric cancer patients treated with neoadjuvant chemotherapy followed by surgical resection.Influence of TS and ABCB1 gene polymorphisms on survival outcomes of 5‑FU-based chemotherapy in a Chinese population of advanced gastric cancer patients.
P2860
Epirubicin combined with oxaliplatin and 5-day continuous infusion of 5-fluorouracil as a first-line treatment for metastatic gastric cancer: treatment outcomes and analysis of prognostic factors.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Epirubicin combined with oxali ...... nalysis of prognostic factors.
@ast
Epirubicin combined with oxali ...... nalysis of prognostic factors.
@en
type
label
Epirubicin combined with oxali ...... nalysis of prognostic factors.
@ast
Epirubicin combined with oxali ...... nalysis of prognostic factors.
@en
prefLabel
Epirubicin combined with oxali ...... nalysis of prognostic factors.
@ast
Epirubicin combined with oxali ...... nalysis of prognostic factors.
@en
P2093
P2860
P1476
Epirubicin combined with oxali ...... nalysis of prognostic factors.
@en
P2093
Chenchen Wang
Dongmei Ji
Jiliang Yin
Mingzu Huang
Weijian Guo
P2860
P2888
P304
P356
10.1007/S00432-014-1754-8
P577
2014-07-18T00:00:00Z